Ablo Prudence Wachinou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ablo Prudence Wachinou has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Gildas Agodokpessi
Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin
6 shared publicationsRaphael Heinzer
Center of Investigation and Research on Sleep (CIRS), University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
6 shared publications- Serge Ade
Faculty of Medicine, University of Parakou, Parakou, Benin
6 shared publications G. Agodokpessi
Faculté des sciences de la santé, université d'Abomey-Calavi, Cotonou, Bénin; Centre national hospitalier universitaire de pneumo-phtisiologie, Cotonou, Bénin
5 shared publicationsDismand Houinato
4 shared publicationsPierre-Marie Preux
4 shared publications
Latest Publications
- 29 September 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (5) , 273
Barriers to the diagnosis and treatment of obstructive sleep apnea in 15 francophone Sub-Saharan African countries: A multicountry survey
Purpose Obstructive sleep apnoea (OSA) is underdiagnosed and undertreated in low-resource settings. This study aimed to comprehensively assess the availability, accessibility, and affordability of diagnostic and therapeutic resources for OSA across 15 francophone sub-Saharan African (FSSA) countries. Methods A cross-sectional survey was conducted from October to December 2025 under the coordination of the Société Africaine de Pneumologie de Langue Française (SAPLF). National experts from 15 countries were purposefully selected through the SAPLF network and completed a standardized questionnaire covering infrastructure, costs, workforce, insurance coverage, and perceived barriers. Quantitative data were analyzed descriptively; qualitative responses were analyzed thematically. Results Polysomnography (PSG) was available in 6/15 countries (40%) and respiratory polygraphy (RP) in 13/15 (86.7%), primarily concentrated in capital cities and private centers. Diagnostic costs were prohibitive: PSG ranged from €221–686 and RP from €69–259, often exceeding the statutory monthly minimum wage (SMW). Continuous positive airway pressure (CPAP) devices were available in 8/15 countries (53.3%) and mandibular advancement devices (MAD) in 5/15 (33.3%), with costs ranging from €381–3,812 and €38–305, respectively. Insurance coverage for CPAP was partial and reported in only three countries. The density of trained practitioners was critically low, with most countries reporting fewer than two per million inhabitants. Conclusion OSA care in francophone sub-Saharan Africa is constrained by centralised diagnostic capacity, prohibitive costs, and a shortage of trained providers. Strengthening training, reducing financial barriers, and integrating sleep medicine into non-communicable disease strategies may improve equity in access.
- 29 September 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (5) , 273
Barriers to the diagnosis and treatment of obstructive sleep apnea in 15 francophone Sub-Saharan African countries: A multicountry survey
Purpose Obstructive sleep apnoea (OSA) is underdiagnosed and undertreated in low-resource settings. This study aimed to comprehensively assess the availability, accessibility, and affordability of diagnostic and therapeutic resources for OSA across 15 francophone sub-Saharan African (FSSA) countries. Methods A cross-sectional survey was conducted from October to December 2025 under the coordination of the Société Africaine de Pneumologie de Langue Française (SAPLF). National experts from 15 countries were purposefully selected through the SAPLF network and completed a standardized questionnaire covering infrastructure, costs, workforce, insurance coverage, and perceived barriers. Quantitative data were analyzed descriptively; qualitative responses were analyzed thematically. Results Polysomnography (PSG) was available in 6/15 countries (40%) and respiratory polygraphy (RP) in 13/15 (86.7%), primarily concentrated in capital cities and private centers. Diagnostic costs were prohibitive: PSG ranged from €221–686 and RP from €69–259, often exceeding the statutory monthly minimum wage (SMW). Continuous positive airway pressure (CPAP) devices were available in 8/15 countries (53.3%) and mandibular advancement devices (MAD) in 5/15 (33.3%), with costs ranging from €381–3,812 and €38–305, respectively. Insurance coverage for CPAP was partial and reported in only three countries. The density of trained practitioners was critically low, with most countries reporting fewer than two per million inhabitants. Conclusion OSA care in francophone sub-Saharan Africa is constrained by centralised diagnostic capacity, prohibitive costs, and a shortage of trained providers. Strengthening training, reducing financial barriers, and integrating sleep medicine into non-communicable disease strategies may improve equity in access.
- Open Access
Prevalence and correlates of comorbid obstructive sleep apnea and restless legs syndrome in a population-based study from Benin, West Africa
Purpose: Comorbid restless legs syndrome (RLS) and obstructive sleep apnea (OSA) -(COROSA)- is poorly characterized in African populations. We estimated its prevalence and correlates in a population-based sample in Benin. Methods: This was a cross-sectional analysis of 1,810 adults aged ≥25 years from the Benin Society and Sleep (BeSAS) study. RLS was defined by International RLS Study Group criteria and OSA by an apnea–hypopnea index ≥5 events/h on home respiratory polygraphy; COROSA required both. Correlates were assessed by multivariable logistic regression; multinomial models compared COROSA with OSA only, RLS only, and neither disorder. An exploratory analysis examined hypertension across eight mutually exclusive sleep-disorder groups, including comorbid insomnia, RLS and OSA (COMIROSA). Results: COROSA prevalence was 3.5% (95% CI 2.7–4.4). Independent correlates were age 40–59 years (aOR 2.91, 95% CI 1.38–6.73), age ≥60 years (aOR 3.76, 1.61–9.35), rural residence (aOR 10.54, 4.94–25.43), overweight (aOR 2.29, 95% CI: 1.16–4.49), obesity (aOR 3.83, 95% CI: 1.75–8.31), and insomnia (aOR 2.49, 1.37–4.50). Relative to OSA only, COROSA was associated with hypertension and insomnia; relative to RLS only, obesity was the main distinguishing factor. Hypertension was associated with COROSA and COMIROSA, with a larger estimate for COMIROSA (aOR 4.03 vs 2.64). Conclusion: COROSA affected 3.5% of adults in Benin and co-occurred with obesity, hypertension and insomnia. Screening for overlapping sleep disorders may improve identification of high-risk individuals. COMIROSA remains a hypothesis requiring validation in larger longitudinal studies. Brief summary: The coexistence of obstructive sleep apnea and restless legs syndrome is insufficiently documented in African populations despite the growing burden of sleep disorders in the region. This study provides the first population-based study estimate of comorbid obstructive sleep apnea and restless legs syndrome in sub-Saharan Africa. Our findings suggest that individuals with both disorders represent a clinically important subgroup with substantial cardiometabolic burden and insomnia. They also raise the possibility of an even more complex overlap involving chronic insomnia, restless legs syndrome, and obstructive sleep apnea, which warrants validation in future studies. These results support more integrated approaches to screening and management of these coexisting sleep disorders in resource-limited settings.
Open AccessPrevalence and correlates of comorbid obstructive sleep apnea and restless legs syndrome in a population-based study from Benin, West Africa
Purpose: Comorbid restless legs syndrome (RLS) and obstructive sleep apnea (OSA) -(COROSA)- is poorly characterized in African populations. We estimated its prevalence and correlates in a population-based sample in Benin. Methods: This was a cross-sectional analysis of 1,810 adults aged ≥25 years from the Benin Society and Sleep (BeSAS) study. RLS was defined by International RLS Study Group criteria and OSA by an apnea–hypopnea index ≥5 events/h on home respiratory polygraphy; COROSA required both. Correlates were assessed by multivariable logistic regression; multinomial models compared COROSA with OSA only, RLS only, and neither disorder. An exploratory analysis examined hypertension across eight mutually exclusive sleep-disorder groups, including comorbid insomnia, RLS and OSA (COMIROSA). Results: COROSA prevalence was 3.5% (95% CI 2.7–4.4). Independent correlates were age 40–59 years (aOR 2.91, 95% CI 1.38–6.73), age ≥60 years (aOR 3.76, 1.61–9.35), rural residence (aOR 10.54, 4.94–25.43), overweight (aOR 2.29, 95% CI: 1.16–4.49), obesity (aOR 3.83, 95% CI: 1.75–8.31), and insomnia (aOR 2.49, 1.37–4.50). Relative to OSA only, COROSA was associated with hypertension and insomnia; relative to RLS only, obesity was the main distinguishing factor. Hypertension was associated with COROSA and COMIROSA, with a larger estimate for COMIROSA (aOR 4.03 vs 2.64). Conclusion: COROSA affected 3.5% of adults in Benin and co-occurred with obesity, hypertension and insomnia. Screening for overlapping sleep disorders may improve identification of high-risk individuals. COMIROSA remains a hypothesis requiring validation in larger longitudinal studies. Brief summary: The coexistence of obstructive sleep apnea and restless legs syndrome is insufficiently documented in African populations despite the growing burden of sleep disorders in the region. This study provides the first population-based study estimate of comorbid obstructive sleep apnea and restless legs syndrome in sub-Saharan Africa. Our findings suggest that individuals with both disorders represent a clinically important subgroup with substantial cardiometabolic burden and insomnia. They also raise the possibility of an even more complex overlap involving chronic insomnia, restless legs syndrome, and obstructive sleep apnea, which warrants validation in future studies. These results support more integrated approaches to screening and management of these coexisting sleep disorders in resource-limited settings.
- Open Access
- 15 May 2026
- Published by Elsevier in Sleep Medicine: X
- Vol. 11
Performance of six screening scores for obstructive sleep apnoea in an African population: findings from the BeSAS cross-sectional study
- 15 May 2026
- Published by Elsevier in Sleep Medicine: X
- Vol. 11
Open AccessPerformance of six screening scores for obstructive sleep apnoea in an African population: findings from the BeSAS cross-sectional study
- Open Access
- 23 March 2026
- Published by Elsevier in The Lancet Regional Health - Africa
- Vol. 2
Urbanisation, lifestyle, and sleep health in West Africa: the Benin Society and Sleep (BeSAS) cross-sectional study
- 23 March 2026
- Published by Elsevier in The Lancet Regional Health - Africa
- Vol. 2
Open AccessUrbanisation, lifestyle, and sleep health in West Africa: the Benin Society and Sleep (BeSAS) cross-sectional study
- Open Access
- 2 February 2026
- Published by Open Exploration Publishing in Exploration of asthma & allergy
- Vol. 4
Prevalence and factors associated with work-related asthma among carpenters in Parakou, northern Benin
Aim: Woodworking exposes carpenters to a higher risk of developing asthma or worsening pre-existing asthma. The objective of this study was to determine the prevalence of and factors associated with work-related asthma (WRA) among carpenters in Parakou in 2024. Methods: This was a cross-sectional, descriptive, and analytical study with prospective data collection conducted from June to September 2024. Following a voluntary survey, the included carpenters were interviewed using the Occupational Asthma Screening Questionnaire-11 (OASQ-11) to assess the relationship between asthma symptoms and the occupational environment. Peak expiratory flow (PEF) variability and spirometry were also measured. Data were analyzed using R software version 4.4.1. Factors associated with WRA were identified using simple and multiple logistic regression analyses. Results: Out of 153 carpenters/apprentices in 117 workshops, 144 (94.1%) were included, all of whom were male. The mean age was 35.9 ± 12.1 years. Among them, 15 (10.4%) had a WRA profile, including 10 (6.9%; 95% CI: 3.8–12.3) with occupational asthma and 5 (3.5%; 95% CI: 1.5–7.9) with work-aggravated asthma. Asthma was confirmed in 7 of the 15 carpenters suspected of having WRA through PEF variability measurement and spirometry. Simple and multiple logistic regression analyses identified a history of allergic rhinitis (aOR = 3.90; p = 0.033) and urticaria (aOR = 8.21; p = 0.002) as factors significantly associated with WRA. Conclusions: The prevalence of WRA among carpenters in Parakou is not negligible, particularly occupational asthma. Awareness campaigns, education for carpenters, regular monitoring of working conditions, and systematic medical follow-up of exposed workers could help preserve their respiratory health.
- 2 February 2026
- Published by Open Exploration Publishing in Exploration of asthma & allergy
- Vol. 4
Open AccessPrevalence and factors associated with work-related asthma among carpenters in Parakou, northern Benin
Aim: Woodworking exposes carpenters to a higher risk of developing asthma or worsening pre-existing asthma. The objective of this study was to determine the prevalence of and factors associated with work-related asthma (WRA) among carpenters in Parakou in 2024. Methods: This was a cross-sectional, descriptive, and analytical study with prospective data collection conducted from June to September 2024. Following a voluntary survey, the included carpenters were interviewed using the Occupational Asthma Screening Questionnaire-11 (OASQ-11) to assess the relationship between asthma symptoms and the occupational environment. Peak expiratory flow (PEF) variability and spirometry were also measured. Data were analyzed using R software version 4.4.1. Factors associated with WRA were identified using simple and multiple logistic regression analyses. Results: Out of 153 carpenters/apprentices in 117 workshops, 144 (94.1%) were included, all of whom were male. The mean age was 35.9 ± 12.1 years. Among them, 15 (10.4%) had a WRA profile, including 10 (6.9%; 95% CI: 3.8–12.3) with occupational asthma and 5 (3.5%; 95% CI: 1.5–7.9) with work-aggravated asthma. Asthma was confirmed in 7 of the 15 carpenters suspected of having WRA through PEF variability measurement and spirometry. Simple and multiple logistic regression analyses identified a history of allergic rhinitis (aOR = 3.90; p = 0.033) and urticaria (aOR = 8.21; p = 0.002) as factors significantly associated with WRA. Conclusions: The prevalence of WRA among carpenters in Parakou is not negligible, particularly occupational asthma. Awareness campaigns, education for carpenters, regular monitoring of working conditions, and systematic medical follow-up of exposed workers could help preserve their respiratory health.
- 7 November 2025
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 42 (9-10) , 441-453
Syndrome d’apnées du sommeil : Profils cliniques, polygraphiques et évolutifs à Cotonou
- 7 November 2025
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 42 (9-10) , 441-453
Syndrome d’apnées du sommeil : Profils cliniques, polygraphiques et évolutifs à Cotonou
- Open Access
- 9 May 2025
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 20 (Vol. 20 (2)
Tuberculosis prevalence and associated factors among persons infected with human immunodeficiency virus in three West African countries (Benin, Guinea, Senegal)
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality in people living with human immunodeficiency virus (HIV). Data are very scarce on the burden of TB in HIV patients in Sub-saharan African populations. This study aimed to determine the prevalence of pulmonary tuberculosis (PTB) and associated factors among people living with human immunodeficiency virus (HIV) in three West African countries: Benin, Guinea, and Senegal. Methods: A cross-sectional study was conducted among people living with HIV in three outpatient care centres (one in each country). All HIV-positive patients included in this study were routinely screened for PTB using microscopy, GeneXpert and culture. Participants free of TB were reassessed clinically and biologically six months later. Data were analyzed using R-3.4.3 software. Logistic regression was used to identify factors associated with PTB. Results: A total of 2859 participants were enrolled in the study, of whom 2820 were screened for TB, 1000 were ARV-naive (35.46%), and 1820 were on ARV prior to screening (64.54%). A total of 127 cases of bacteriologically confirmed PTB (BCPTB) were diagnosed: 117 at baseline and 10 at the 6-month visit. The overall prevalence of BCPTB was 7.90% [95% CI: 6.38-9.75] for ARV-naive participants and 2.64% [95% CI: 1.99-3.48] for participants on ARV at the time of screening. Participants from Guinea were more likely to be diagnosed with TB (OR: 2.95 [95% CI: 1.60-5.45], p=0.001). Underweight HIV-positive patients had higher odds of TB diagnosis (OR: 2.09 [95% CI: 1.40-3.12], p<0.001), while overweight/obesity was associated with lower odds of TB (OR: 0.35 [95% CI: 0.15-0.81], p=0.015). Other factors associated with BCPTB in HIV patients were male sex (OR: 1.81 [95% CI: 1.18-2.77], p=0.007), CD4 count <200/ml (OR: 2.24 [95% CI: 1.15-4.37], p=0.018), and irregular disease follow-up (OR: 2.57 [95% CI: 1.29-5.15], p=0.018). Conclusion: The prevalence of TB among people living with HIV is high in Benin, Guinea and Senegal. These results highlight the need to improve TB screening and diagnosis in PLHIV, especially in ARV-naive patients.
- 9 May 2025
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 20 (Vol. 20 (2)
Open AccessTuberculosis prevalence and associated factors among persons infected with human immunodeficiency virus in three West African countries (Benin, Guinea, Senegal)
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality in people living with human immunodeficiency virus (HIV). Data are very scarce on the burden of TB in HIV patients in Sub-saharan African populations. This study aimed to determine the prevalence of pulmonary tuberculosis (PTB) and associated factors among people living with human immunodeficiency virus (HIV) in three West African countries: Benin, Guinea, and Senegal. Methods: A cross-sectional study was conducted among people living with HIV in three outpatient care centres (one in each country). All HIV-positive patients included in this study were routinely screened for PTB using microscopy, GeneXpert and culture. Participants free of TB were reassessed clinically and biologically six months later. Data were analyzed using R-3.4.3 software. Logistic regression was used to identify factors associated with PTB. Results: A total of 2859 participants were enrolled in the study, of whom 2820 were screened for TB, 1000 were ARV-naive (35.46%), and 1820 were on ARV prior to screening (64.54%). A total of 127 cases of bacteriologically confirmed PTB (BCPTB) were diagnosed: 117 at baseline and 10 at the 6-month visit. The overall prevalence of BCPTB was 7.90% [95% CI: 6.38-9.75] for ARV-naive participants and 2.64% [95% CI: 1.99-3.48] for participants on ARV at the time of screening. Participants from Guinea were more likely to be diagnosed with TB (OR: 2.95 [95% CI: 1.60-5.45], p=0.001). Underweight HIV-positive patients had higher odds of TB diagnosis (OR: 2.09 [95% CI: 1.40-3.12], p<0.001), while overweight/obesity was associated with lower odds of TB (OR: 0.35 [95% CI: 0.15-0.81], p=0.015). Other factors associated with BCPTB in HIV patients were male sex (OR: 1.81 [95% CI: 1.18-2.77], p=0.007), CD4 count <200/ml (OR: 2.24 [95% CI: 1.15-4.37], p=0.018), and irregular disease follow-up (OR: 2.57 [95% CI: 1.29-5.15], p=0.018). Conclusion: The prevalence of TB among people living with HIV is high in Benin, Guinea and Senegal. These results highlight the need to improve TB screening and diagnosis in PLHIV, especially in ARV-naive patients.
- 25 March 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (2) , 1-9
Prevalence of restless leg syndrome and associated comorbidities in a sub-saharan African general population: results from the Benin Society and Sleep (BeSAS) study
Purpose To assess the prevalence of Restless Leg Syndrome (RLS) and associated comorbidities among adults in rural and urban areas of Benin, a Sub-Saharan country, where limited data exists on its burden and clinical relevance. Methods A cross-sectional population-based study was conducted in Benin. RLS was identified using the standardized International Restless Legs Questionnaire. Demographic data and lifestyle data (alcohol consumption, smoking) were self-reported by participants, while precise anthropometric measurements (height, weight, BMI) and clinical parameters (blood pressure, blood glucose) were obtained using standardized protocols to assess nutritional status and detect hypertension and diabetes. Sleep quality was evaluated using three validated instruments: the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, and the Insomnia Severity Index. Data were collected through face-to-face interviews conducted by trained personnel using KoBoToolbox software on digital tablets. Logistic regression models were used to determine the relationship between RLS and associated comorbidities. Results Among 2,909 participants (58.7% urban, mean age 44.7 years, 61.2% female), RLS prevalence was 5.0% [95% CI: 4.3–5.9], with higher rates in rural (9.4%) versus urban areas (1.9%). Prevalence increased with age (1.7% in 25–34 years to 12.5% in ≥ 65 years) and was higher in females (5.9%) than males (3.5%). RLS showed significant associations with hypertension (adjusted odds ratio [aOR] = 1.56, 95% CI: 1.04–2.35, p = 0.03) and poor sleep quality (aOR = 3.07, 95% CI: 2.07–4.57, p < 0.001). Conclusion RLS shows notable prevalence in Benin with rural-urban disparities and significant associations with hypertension and poor sleep quality, highlighting the need for further research in sub-Saharan populations.
- 25 March 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (2) , 1-9
Prevalence of restless leg syndrome and associated comorbidities in a sub-saharan African general population: results from the Benin Society and Sleep (BeSAS) study
Purpose To assess the prevalence of Restless Leg Syndrome (RLS) and associated comorbidities among adults in rural and urban areas of Benin, a Sub-Saharan country, where limited data exists on its burden and clinical relevance. Methods A cross-sectional population-based study was conducted in Benin. RLS was identified using the standardized International Restless Legs Questionnaire. Demographic data and lifestyle data (alcohol consumption, smoking) were self-reported by participants, while precise anthropometric measurements (height, weight, BMI) and clinical parameters (blood pressure, blood glucose) were obtained using standardized protocols to assess nutritional status and detect hypertension and diabetes. Sleep quality was evaluated using three validated instruments: the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, and the Insomnia Severity Index. Data were collected through face-to-face interviews conducted by trained personnel using KoBoToolbox software on digital tablets. Logistic regression models were used to determine the relationship between RLS and associated comorbidities. Results Among 2,909 participants (58.7% urban, mean age 44.7 years, 61.2% female), RLS prevalence was 5.0% [95% CI: 4.3–5.9], with higher rates in rural (9.4%) versus urban areas (1.9%). Prevalence increased with age (1.7% in 25–34 years to 12.5% in ≥ 65 years) and was higher in females (5.9%) than males (3.5%). RLS showed significant associations with hypertension (adjusted odds ratio [aOR] = 1.56, 95% CI: 1.04–2.35, p = 0.03) and poor sleep quality (aOR = 3.07, 95% CI: 2.07–4.57, p < 0.001). Conclusion RLS shows notable prevalence in Benin with rural-urban disparities and significant associations with hypertension and poor sleep quality, highlighting the need for further research in sub-Saharan populations.
- Open Access
Challenges and knowledge gaps in the management of non-tuberculous mycobacterial pulmonary disease in sub-Saharan African countries with a high tuberculosis burden: a scoping review
Introduction In sub-Saharan African (SSA) countries endemic for tuberculosis (TB), previous TB is a significant risk factor for non-tuberculous mycobacterial pulmonary disease (NTM-PD). The deployment of GeneXpert MTB/RIF in pulmonary TB diagnostic work-up regularly identifies symptomatic patients with a positive smear microscopy but negative GeneXpert, indicative of NTM presence. This scoping review outlines recent evidence for NTM-PD diagnosis and management in SSA. Objective The review’s objective was to outline the risk factors, available diagnostics, management options and outcomes of NTM-PD in high-burden TB settings in SSA using the population-concept-context framework. Design and data sources We searched existing literature from PubMed, Web of Science, African Journals Online, Google Scholar and grey literature. Studies published between January 2005 and December 2022 were retained. Data were extracted into Rayyan software and Mendeley and summarised using Excel. Results We identified 785 potential articles, of which 105 were included in the full-text review, with 7 papers retained. Included articles used international criteria for diagnosing NTM-PD. Multiple papers were excluded due to non-application of the criteria, suggesting challenging application in the SSA setting. Identified risk factors include previous TB, smoking and mining. Most commonly, chest radiography and not CT was used for the radiological diagnosis of PD, which may miss early changes related to NTM-PD. Molecular methods for NTM species identification were employed in research settings, usually at referral centres, but were unavailable for routine care. Most studies did not report a standardised approach to treatment and they were not offered treatment for the specific disease, marking a lack of guidance in treatment decision-making. When treatment was provided, the outcome was often not reported due to the lack of implementation of standardised outcome definitions. Conclusions These outlined challenges present a unique opportunity for researchers to undertake further studies in NTM-PD and proffer solutions more applicable to SSA.
Open AccessChallenges and knowledge gaps in the management of non-tuberculous mycobacterial pulmonary disease in sub-Saharan African countries with a high tuberculosis burden: a scoping review
Introduction In sub-Saharan African (SSA) countries endemic for tuberculosis (TB), previous TB is a significant risk factor for non-tuberculous mycobacterial pulmonary disease (NTM-PD). The deployment of GeneXpert MTB/RIF in pulmonary TB diagnostic work-up regularly identifies symptomatic patients with a positive smear microscopy but negative GeneXpert, indicative of NTM presence. This scoping review outlines recent evidence for NTM-PD diagnosis and management in SSA. Objective The review’s objective was to outline the risk factors, available diagnostics, management options and outcomes of NTM-PD in high-burden TB settings in SSA using the population-concept-context framework. Design and data sources We searched existing literature from PubMed, Web of Science, African Journals Online, Google Scholar and grey literature. Studies published between January 2005 and December 2022 were retained. Data were extracted into Rayyan software and Mendeley and summarised using Excel. Results We identified 785 potential articles, of which 105 were included in the full-text review, with 7 papers retained. Included articles used international criteria for diagnosing NTM-PD. Multiple papers were excluded due to non-application of the criteria, suggesting challenging application in the SSA setting. Identified risk factors include previous TB, smoking and mining. Most commonly, chest radiography and not CT was used for the radiological diagnosis of PD, which may miss early changes related to NTM-PD. Molecular methods for NTM species identification were employed in research settings, usually at referral centres, but were unavailable for routine care. Most studies did not report a standardised approach to treatment and they were not offered treatment for the specific disease, marking a lack of guidance in treatment decision-making. When treatment was provided, the outcome was often not reported due to the lack of implementation of standardised outcome definitions. Conclusions These outlined challenges present a unique opportunity for researchers to undertake further studies in NTM-PD and proffer solutions more applicable to SSA.
- 4 December 2023
- Vol. 40 (12 Suppl 1) , S39-S40
EVALUATION OF A MODIFIED EPWORTH SLEEPINESS SCALE TO RELIABLY ASSESS EXCESSIVE DAYTIME SLEEPINESS IN LOW-INCOME COUNTRIES: RESULTS FROM THE BENIN SOCIETY AND SLEEP (BESAS) STUDY.
The Epworth Sleepiness Scale (ESS) is a tool widely used to assess excessive daytime sleepiness. Unfortunately, it is not reliable in low-income countries where situations such as reading a book, watching TV or driving a car are not common. The aim of this study was thus to assess the performance of a modified version of the Epworth scale in a low-income country. We used data from the Benin Society and Sleep (BeSAS) study where the ESS and a modified ESS (mESS) were administered to participants. In the mESS, questions four questions over eight were redesigned to reflect common living situations in Benin. The internal coherence of the mESS was assessed using the Cronbach alpha coefficient (CAC). The discriminatory ability of the scale was assessed by comparing the mean scores according to reported sleep quality, insomnia complaints and apnea-hypopnea index (AHI). A total of 2909 participants were recruited, 1129 were male (38.9%) with a mean age (SD) of 44.7 (14.5) y. Overall, 52.4% (1526) completed all the mESS questions while 453 (15.6%) completed the standard ESS. The CAC of the mES was 0.86 showing good internal coherence. Concerning the discriminatory ability, mean scores for mESS were 7.8 for participants with ISI < 8 vs 9.2 for participants with ISI≥8 (p<0.001), 7.8 for participants withPSQI<5 vs 8.3 for participants with PSQI≥5 (p=0.03). No difference was found when comparing the participants participants using different cut-offs of AHI (15 and 30). The mES is more reliable than ES in the Beninese population. mESS shows good internal coherence and differentiates between insomniacs vs non-insomniacs and between good and poor sleepers. Although the mES is not a perfect score, it appears more relevant in the Benin population than the original Epworth scale but needs further validation/improvement in other low-income countries.
- 4 December 2023
- Vol. 40 (12 Suppl 1) , S39-S40
EVALUATION OF A MODIFIED EPWORTH SLEEPINESS SCALE TO RELIABLY ASSESS EXCESSIVE DAYTIME SLEEPINESS IN LOW-INCOME COUNTRIES: RESULTS FROM THE BENIN SOCIETY AND SLEEP (BESAS) STUDY.
The Epworth Sleepiness Scale (ESS) is a tool widely used to assess excessive daytime sleepiness. Unfortunately, it is not reliable in low-income countries where situations such as reading a book, watching TV or driving a car are not common. The aim of this study was thus to assess the performance of a modified version of the Epworth scale in a low-income country. We used data from the Benin Society and Sleep (BeSAS) study where the ESS and a modified ESS (mESS) were administered to participants. In the mESS, questions four questions over eight were redesigned to reflect common living situations in Benin. The internal coherence of the mESS was assessed using the Cronbach alpha coefficient (CAC). The discriminatory ability of the scale was assessed by comparing the mean scores according to reported sleep quality, insomnia complaints and apnea-hypopnea index (AHI). A total of 2909 participants were recruited, 1129 were male (38.9%) with a mean age (SD) of 44.7 (14.5) y. Overall, 52.4% (1526) completed all the mESS questions while 453 (15.6%) completed the standard ESS. The CAC of the mES was 0.86 showing good internal coherence. Concerning the discriminatory ability, mean scores for mESS were 7.8 for participants with ISI < 8 vs 9.2 for participants with ISI≥8 (p<0.001), 7.8 for participants withPSQI<5 vs 8.3 for participants with PSQI≥5 (p=0.03). No difference was found when comparing the participants participants using different cut-offs of AHI (15 and 30). The mES is more reliable than ES in the Beninese population. mESS shows good internal coherence and differentiates between insomniacs vs non-insomniacs and between good and poor sleepers. Although the mES is not a perfect score, it appears more relevant in the Benin population than the original Epworth scale but needs further validation/improvement in other low-income countries.